The following
originally appeared on Girlie
Girl Army
.

Susan G. Komen
for the Cure

was hit with a tidal wave of backlash when it announced that it was pulling $680,000
in grants to Planned Parenthood that had covered breast-cancer screenings for underprivileged
women. As the people behind all the pink went red in the face, Komen decided that
the only way to bail out the sinking ship was for CEO Nancy Brinker to resign.
Theoretically, she did. But she’s still there, in a new position: chair of the
Komen Board Executive Committee. No one has replaced her as CEO, and she still
holds the title on Komen’s website. According to recent news
reports
,
in addition to still seemingly being at the helm of the organization, she just
landed a tidy little raise—64 percent, to be precise—bringing her salary to nearly
$685,000
. Quite an interesting number. And surprisingly, she seems to have done
it without much of a flap.

Komen
had to backpedal and reinstate Planned Parenthood’s grants. But even so, the
organization spent a measly 11 percent of its $420 million in annual donations
on screening
. And it allotted 15 percent for research. So are women actually going pink “for the cure” or for other things—such as Brinker’s reported
five-star accommodations, private flights, and luncheons with lobster flown in
from Maine?

Equally troubling is the type of “research”
that Komen funds: archaic experiments on animals that for more than 40 years still haven’t produced a cure
. “The history of cancer research has been a
history of curing cancer in the mouse,” Richard Klausner, former head of
the National Cancer Institute (NCI), has observed. “We have cured mice of
cancer for decades, and it simply didn’t work in humans.” The same is true
for the millions of rats, guinea pigs, rabbits, cats, dogs, monkeys, and other animals who have died in the
name of cancer experimentation
—because their genetic makeup is vastly different from
ours. The NCI now uses human cancer cells, taken by biopsy during surgery, to
perform first-stage
testing for new anti-cancer drugs
, giving us all a much better shot at combating cancer.
But while other organizations such as Komen waste funds on experiments that
have proven time and again not to work, women with a family history of breast
cancer, like Angelina
Jolie
, are so fearful that they are preemptively having
their breasts removed.

As
a woman, an animal advocate, and a granddaughter whose dear grandmother died of
breast cancer at age 64, I am outraged by Komen’s wastefulness and apparent
disregard for underprivileged women. We deserve better than this.

A
host of organizations dedicate their proceeds to offering screenings for
underserved women and finding a cure through cutting-edge non-animal testing
methods. Among them are the American Breast Cancer Foundation, the Dr. Susan
Love Research Foundation, the National Breast Cancer Coalition, and the United
Breast Cancer Research Society. PETA has compiled a complete list

To
end breast cancer, we have to think outside the pink
.

GD Star Rating
loading...
How Did Komen Head Nancy Brinker's 64 Percent Raise Go Under the Radar?, 10.0 out of 10 based on 1 rating

Article source: PETA Files

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.